Vivo Capital’s Tourmaline Bio TRML Stock Holding History

Vivo Capital’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-591,882	Closed	-$28.3M	–	53
2025 Q3	$28.3M	Hold	591,882	–	–	2.28%	15
2025 Q2	$9.46M	Hold	591,882	–	–	0.97%	19
2025 Q1	$9M	Hold	591,882	–	–	1.19%	19
2024 Q4	$12M	Hold	591,882	–	–	1.34%	16
2024 Q3	$15.2M	Hold	591,882	–	–	1.26%	16
2024 Q2	$7.61M	Hold	591,882	–	–	0.7%	26
2024 Q1	$13.6M	Hold	591,882	–	–	1.07%	22
2023 Q4	$15.5M	Buy	+591,882	New	+$11.8M	1.27%	15

Vivo Capital's TRML Position: Q4 2025 in Review

Vivo Capital sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 591,882 shares — an estimated $28.3M sold.

Vivo Capital first reported a position in TRML in Q4 2023 and held it in 8 quarters. The position peaked at $28.3M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Vivo Capital reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Vivo Capital sold 591,882 Tourmaline Bio shares in Q4 2025, an estimated $28.3M.
Vivo Capital first reported a position in Tourmaline Bio in Q4 2023 and held it in 8 quarters.
Vivo Capital's Tourmaline Bio position peaked at $28.3M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Vivo Capital's 13F filing for Q4 2025, filed 13 Feb 2026.